Rayyan June 18, 2026 Pharmacovigilance in 2026 – What is Expected to Change in the Regulatory Landscape Across Regions? Pharma manufacturers are rapidly launching their products across borders, directly intensifying the burden on safety… Read More
Rayyan June 18, 2026 FDA Vowes Improved Adverse Event Reporting With AEMS The FDA announced today the launch of the FDA Adverse Event Monitoring System (AEMS).1 This new… Read More
Rayyan June 17, 2026 The State of Pharma Packaging in 2026: Trends Every Packaging Leader Should Know In 2026, packaging leaders face challenges tied to patient safety, stricter regulations, and pressure for… Read More